Semaglutide Plus IL-2: Clinical Trials

1 trial of Semaglutide Plus IL-2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Semaglutide Plus IL-2: new trials by email Literature Review of Semaglutide Plus IL-2 trials Research Report on Semaglutide Plus IL-2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
IL-2 (Aldesleukin), Semaglutide Plus IL-2, Placebo - Alzheimer Dementia (AD)
Phase 1 / Phase 2RecruitingThe Methodist Hospital Research Institute302026-09-012026-09-23

Conditions studied

Alzheimer Disease (1)  ·  Inflammation (1)

Sponsors

The Methodist Hospital Research Institute (1)

Countries

United States (1)